These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15955002)

  • 1. Avoiding simplistic interpretations: comment on Degenhardt et al. 2005.
    Tyndall M
    Addiction; 2005 Jul; 100(7):923-4; discussion 930-2. PubMed ID: 15955002
    [No Abstract]   [Full Text] [Related]  

  • 2. Supply control does work: the case from Australia.
    Hao W
    Addiction; 2005 Jul; 100(7):926-7; discussion 930-2. PubMed ID: 15955005
    [No Abstract]   [Full Text] [Related]  

  • 3. Heroin, supply side interventions and crime.
    Reuter P
    Addiction; 2005 Jul; 100(7):925-6; discussion 930-2. PubMed ID: 15955004
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of supply reduction in an evidence-based illicit drug strategy: comments on Smithson et al. (2005).
    Wood E
    Addiction; 2005 Aug; 100(8):1194-5. PubMed ID: 16042650
    [No Abstract]   [Full Text] [Related]  

  • 5. Learning from uncommon events: comment on Degenhardt et al. 2005.
    Jaffe JH
    Addiction; 2005 Jul; 100(7):921-2; discussion 930-2. PubMed ID: 15955000
    [No Abstract]   [Full Text] [Related]  

  • 6. The co-morbidities of cannabis use: a comment on Degenhardt et al.
    Fergusson DM
    Addiction; 2001 Dec; 96(12):1861-3. PubMed ID: 11791535
    [No Abstract]   [Full Text] [Related]  

  • 7. What caused the recent reduction in heroin supply in Australia?
    Wodak A
    Int J Drug Policy; 2008 Aug; 19(4):279-86. PubMed ID: 18554895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supply control policy, harm reduction and context dependence.
    Weatherburn D
    Addiction; 2005 Jul; 100(7):927-8; discussion 930-2. PubMed ID: 15955006
    [No Abstract]   [Full Text] [Related]  

  • 9. Public health and politics: the demise of the ACT heroin trial.
    Wodak AD
    Med J Aust; 1997 Oct; 167(7):348-9. PubMed ID: 9379971
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of Federal drug law enforcement on the supply of heroin in Australia.
    Smithson M; McFadden M; Mwesigye SE
    Addiction; 2005 Aug; 100(8):1110-20. PubMed ID: 16042641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin use by hospitals: the debate rages on.
    LeBourdais E
    Health Care (Don Mills); 1986 Oct; 28(7):51-2. PubMed ID: 10318614
    [No Abstract]   [Full Text] [Related]  

  • 12. A little (more) knowledge: comments on Wood et Al. (2006).
    Smithson M
    Addiction; 2006 May; 101(5):622-3; author reply 623-5. PubMed ID: 16669882
    [No Abstract]   [Full Text] [Related]  

  • 13. Availability as a law of addiction.
    Mann RE
    Addiction; 2005 Jul; 100(7):924-5; discussion 930-2. PubMed ID: 15955003
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
    Brewer C
    Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398
    [No Abstract]   [Full Text] [Related]  

  • 15. The proposal to make heroin available legally to intravenous drug abusers.
    Foy A; Pryor C; Drinkwater V; White A; Walsh R
    Med J Aust; 1989 Apr; 150(8):465-6. PubMed ID: 2716689
    [No Abstract]   [Full Text] [Related]  

  • 16. The costs and consequences of three policy options for reducing heroin dependency.
    Moore TJ; Ritter A; Caulkins JP
    Drug Alcohol Rev; 2007 Jul; 26(4):369-78. PubMed ID: 17564872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How they do it better. Abuse as a disease, not a crime.
    Grose TK
    US News World Rep; 2007 Mar 26-Apr 2; 142(11):59. PubMed ID: 17447405
    [No Abstract]   [Full Text] [Related]  

  • 18. When commercial interests differ from public health interests: comments on Sato et al.
    Slade J
    Addiction; 2000 Dec; 95(12):1869-70. PubMed ID: 11218369
    [No Abstract]   [Full Text] [Related]  

  • 19. The availability of heroin.
    Leyden M
    Med J Aust; 1989 Jan; 150(1):56. PubMed ID: 2909860
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: drug development for neglected diseases: a public health challenge.
    Fehr A; Thürmann P; Razum O
    Trop Med Int Health; 2006 Sep; 11(9):1335-8. PubMed ID: 16930253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.